Opus Genetics, Inc. (IRD)
5.18
-0.10
(-1.89%)
USD |
NASDAQ |
Sep 18, 16:00
5.16
-0.02
(-0.39%)
After-Hours: 20:00
Opus Genetics Total Return Level : 5.18 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 5.18 |
| September 17, 2026 | 5.28 |
| September 16, 2026 | 5.41 |
| September 15, 2026 | 5.82 |
| September 14, 2026 | 5.97 |
| September 11, 2026 | 6.04 |
| September 10, 2026 | 6.07 |
| September 09, 2026 | 5.73 |
| September 08, 2026 | 4.34 |
| September 04, 2026 | 4.67 |
| September 03, 2026 | 4.60 |
| September 02, 2026 | 4.45 |
| September 01, 2026 | 3.83 |
| August 31, 2026 | 3.62 |
| August 28, 2026 | 3.69 |
| August 27, 2026 | 3.85 |
| August 26, 2026 | 3.80 |
| August 25, 2026 | 4.11 |
| August 24, 2026 | 4.03 |
| August 21, 2026 | 4.05 |
| August 20, 2026 | 4.12 |
| August 19, 2026 | 4.07 |
| August 18, 2026 | 3.69 |
| August 17, 2026 | 3.65 |
| August 14, 2026 | 3.61 |
| Date | Value |
|---|---|
| August 13, 2026 | 3.72 |
| August 12, 2026 | 3.76 |
| August 11, 2026 | 3.88 |
| August 10, 2026 | 3.66 |
| August 07, 2026 | 3.66 |
| August 06, 2026 | 3.72 |
| August 05, 2026 | 3.78 |
| August 04, 2026 | 3.71 |
| August 03, 2026 | 3.64 |
| July 31, 2026 | 3.71 |
| July 30, 2026 | 3.84 |
| July 29, 2026 | 3.47 |
| July 28, 2026 | 3.41 |
| July 27, 2026 | 3.35 |
| July 24, 2026 | 3.08 |
| July 23, 2026 | 2.92 |
| July 22, 2026 | 3.05 |
| July 21, 2026 | 3.06 |
| July 20, 2026 | 3.05 |
| July 17, 2026 | 3.27 |
| July 16, 2026 | 3.28 |
| July 15, 2026 | 3.48 |
| July 14, 2026 | 3.56 |
| July 13, 2026 | 3.81 |
| July 10, 2026 | 3.92 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Faeth Therapeutics, Inc. | 34.50 |
| Perspective Therapeutics, Inc. | 2.88 |
| Rezolute, Inc. | 3.84 |
| Praxis Precision Medicines, Inc. | 298.95 |
| Nuvectis Pharma, Inc. | 22.00 |